Published in Medical Patent Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Stem Cell Innovations, Inc.
Report 1: The High Q Foundation Inc. (High Q), a foundation that supports research aimed at finding treatments for Huntington's disease, and Stem Cell Innovations, Inc. (SCI) (OTCBB: SCLL) announced that they have entered into a two-year R&D alliance. The organizations will apply SCI's PluriCells(TM) to develop Huntington's disease specific human cell systems for the purpose of drug discovery. Under the terms of their agreement, SCI will receive up to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly